FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
The American Journal of Managed Care16h
Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression
Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD ...
Hosted on MSN1h
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
KJZZ9h
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
Psychology Today16h
Treatment of Addiction
Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...
Tom's Guide19h
Samsung Galaxy S25: All the rumors so far
The countdown to when we finally get to see Samsung's next big phone is now a matter of hours. The phone maker's next Galaxy Unpacked event takes place on January 22. And the Galaxy S25 is almost ...
BMJ16h
EPILEPSY IN TOURETTE SYNDROME
Objective Tourette Syndrome (TS) is a neurodevelopmental disorder frequently ... clinical descriptions and treatment. Cases where epilepsy had been inappropriately suspected or misdiagnosed were ...